![Medicine / Chronic obstructive pulmonary disease / Smoking / Respiratory therapy / Acute exacerbation of chronic obstructive pulmonary disease / Long-acting beta-adrenoceptor agonist / Asthma / Beta2-adrenergic agonist / Fluticasone furoate / Chronic lower respiratory diseases / Pulmonology / Health Medicine / Chronic obstructive pulmonary disease / Smoking / Respiratory therapy / Acute exacerbation of chronic obstructive pulmonary disease / Long-acting beta-adrenoceptor agonist / Asthma / Beta2-adrenergic agonist / Fluticasone furoate / Chronic lower respiratory diseases / Pulmonology / Health](https://www.pdfsearch.io/img/6571a95161dd7e927d0bb1ee28019a83.jpg)
| Open Document File Size: 3,33 MBShare Result on Facebook
City Hyattsville / MMWR / / Company GlaxoSmithKline / / Country United States / / Facility Blood Institute / / MedicalCondition blister / both asthma / Pneumonia / COPD / disease / Blood Diseases / breast cancer / diabetes / Asthma / / Organization National Heart / Lung / and Blood Institute / Medicare / National Center for Health Statistics / dail / / Person Katharine Knobil / / Position Vice President / Clinical Development GlaxoSmithKline A-2 Impact / / URL www.nhlbi.nih.gov/resources/docs/cht-book.htm / /
SocialTag |